The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer-Reference-Cited by-同舟云学术

The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer

Author:

Pohlman Alexander W.¹,Moudgalya Hita²,Jordano Lia³,Lobato Gabriela C.⁴,Gerard David²,Liptay Michael J.⁵,Seder Christopher W.⁵,Borgia Jeffrey A.²⁴⁶

Affiliation:

1. Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA

2. Department of Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL 60612, USA

3. Department of General Surgery, Rush University Medical Center, Chicago, IL 60612, USA

4. Department of Biochemistry, Rush University Medical Center, Chicago, IL 60612, USA

5. Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL 60612, USA

6. Department of Pathology, Rush University Medical Center, Chicago, IL 60612, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Reference91 articles.

1. American Cancer Society. Cancer Facts & Figures 2021. https://www.cancer.org/content/dam/CRC/PDF/Public/8703.00.pdf.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献